Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LISI S.A. M&A Activity 2010

Aug 31, 2010

1484_iss_2010-08-31_a50bb820-1f4b-44f7-a48f-56c12cc9babc.pdf

M&A Activity

Open in viewer

Opens in your device viewer

Belfort, August 31, 2010

LISI MEDICAL, A SUBSIDIARY OF THE LISI GROUP, ACQUIRES STRYKER CORPORATION'S BENOIST-GIRARD MANUFACTURING FACILITY; ENTERS INTO A MULTI-YEAR SUPPLY AGREEMENT WITH STRYKER

LISI Group (Euronext Paris ISIN code FR0000050353 – FII) today announced that it has finalized a definitive agreement with Stryker Corporation (NYSE:SYK) to:

  • acquire the manufacturing assets of Stryker's Benoist Girard facility located in Caen-Hérouville (France); and
  • manufacture and supply forged orthopaedic components to Stryker within the framework of a five-year contract.

This completes the process initially described in a press release dated December 8, 2009, and it confirms LISI MEDICAL's strategy to strengthen its position as a world-class manufacturer recognized for the quality of its implants and ancillaries while increasing its global market share in the high growth potential market of forged components, including finished products for the reconstructive sector. This transaction takes place while Benoist-Girard S.A.S's works council has initiated legal action regarding its right for information.

In addition, with this transaction, LISI MEDICAL is improving its medium-term visibility thanks to a five-year supply agreement with Stryker Corporation, one of the world's leading medical technology companies.

With a highly skilled and experienced staff of approximately 250, the Benoist-Girard facility, now named "LISI Medical Orthopaedics", specializes in the manufacturing of orthopaedic implants and instruments. Effective September 1, 2010, the entity will be consolidated into LISI Group as a wholly-owned subsidiary.

LISI is a worldwide leading manufacturer of fasteners and assembly components for the Aerospace, Medical, Automotive, and Fragrance-Cosmetics industries. The LISI share is traded on the Eurolist stock exchange, section B and is part of the CAC MID 100 – Next 150 index under ISIN Code FR 0000050353. LISI MEDICAL, a division that comprises Hugueny, Jeropa and Seignol, specializes in the subcontracting of medical implants for groups that develop medical solutions. Its industrial facilities are located in Lyon (France), Tangier (Morocco) and Escondido (California - USA). LISI Group 2009 revenues were 695 million euros, of which approx 19 million euros for LISI MEDICAL. The Company's website address is www.lisi-group.com.

Stryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The Company provides innovative orthopaedic implants as well as state-of-the-art medical and surgical equipment to help people lead more active and more satisfying lives. For more information about Stryker, please visit www.stryker.com.

Contact for LISI Gilles Kohler Tel: +33 (0)3 84 57 00 77 E-mail: [email protected] Website: www.lisi-group.com

Contact for Stryker Aaron Kwittken Tel: 917-697-0473 E-mail: [email protected]